Fundz

Rhaeos, Inc. Raises $2.2 Million In Oversubscribed Seed Round

PRIVATEDec 24, 2021

Amount Raised

$2.2 Million

Round Type

Seed

EvanstonBiotechnologyHealth CareMedicalMedical Device

Description

Rhaeos, Inc., a private, clinical stage medical device company developing a platform wireless and non-invasive wearable sensor initially targeting the neurosurgical suite, today announced the successful closing of its oversubscribed $2.2 million seed financing. The round, which brings a total of over $8 million in dilutive and non-dilutive financing to date, includes participation from Creative Ventures, Portal Innovations, Lateral Capital, Cedars-Sinai Accelerator, Kyto Life Science and Technology, Band of Angels, Northwestern University's NXT Fund, University of Michigan Social Venture Fund, and private investors.

Quick answer

Rhaeos raised $2.2 Million in a Seed round, dated December 24, 2021. Rhaeos is based in Evanston, Illinois, United States.

How much did Rhaeos raise?
Rhaeos raised $2.2 Million in a Seed round on December 24, 2021.
What does Rhaeos do?
Rhaeos, Inc. is a pioneer in medical device wearables for hydrocephalus, with its groundbreaking FlowSense technology designed to monitor cerebrospinal fluid shunt function rapidly and non-invasively.
Where is Rhaeos based and how big is it?
Rhaeos is based in Evanston, Illinois, United States.
Who are the decision-makers at Rhaeos?
Fundz holds 1 contact at Rhaeos, including the Senior R&D Engineer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Rhaeos that raised within 45 days of this round, from Fundz verified event records.

  • Conavi Medical raised an undisclosed amount (Funding Round) on December 15, 2021.
  • medimaps group S.A raised $20M (Funding Round) on December 1, 2021.
  • VERTOS MEDICAL INC raised $17M on November 18, 2021.
  • Fractyl Health raised $20M on January 25, 2022.
  • Faeth Therapeutics raised $20M (Seed) on January 18, 2022.
  • SomnoMed Technologies raised $200K (Pre-Seed) on January 13, 2022.

Who to call at Rhaeos, and when

A new round usually means Rhaeos is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Rhaeos raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rhaeos, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rhaeos. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Rhaeos

Location

Evanston, Illinois, United States

About

Rhaeos, Inc. is a pioneer in medical device wearables for hydrocephalus, with its groundbreaking FlowSense technology designed to monitor cerebrospinal fluid shunt function rapidly and non-invasively. Developed from the world-renowned John A. Rogers Research Group at Northwestern University, the FlowSense system utilizes a small, bandage-sized patch adhered to a patient's skin over the implanted shunt tubing. This FDA breakthrough designated technology wirelessly transmits critical data on shunt functionality to a mobile app within minutes, providing clinicians with real-time information to optimize treatment plans. Rhaeos is a private medical technology company spun out of Northwestern University and is focused on developing wearable sensors to improve the care of people suffering from chronic and difficult-to-treat conditions. The company's novel FlowSense shunt monitor is a non-invasive, wireless, thermal sensor that addresses a clinical unmet need for people with hydrocephalus and is funded by the Steele Foundation for Hope, National Institute of Neurological Disorders and Stroke at the National Institutes of Health, National Science Foundation, MedTech Innovator, the Pediatric Hydrocephalus Foundation, the Southwest Pediatric Device Consortium, the National Capital Consortium for Pediatric Device Innovation, the UCSF-Stanford Pediatric Device Accelerator, the The Consortium for Technology & Innovation in Pediatrics, and public, private, and institutional investors.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Rhaeos raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAlex B., Senior R&D Engineer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Rhaeos's next move

See what Strategic adds

Rhaeos raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.